[1] Chen CJ, Shi Y, Hearn A, Fitzgerald K, Golenbock D, Reed G, et al.: MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J Clin Invest 116: 2262-2271, 2006.
[2] di Giovine FS, Malawista SE, Thornton E, Duff GW: Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution. J Clin Invest 87: 1375-1381, 1991.
[3] Terkeltaub R, Zachariae C, Santoro D, Martin J, Peveri P, Matsushima K: Monocyte-derived neutrophil chemotactic factor/interleukin-8 is a potential mediator of crystal-induced inflammation. Arthritis Rheum 34: 894-903, 1991.
[4] Guerne PA, Terkeltaub R, Zuraw B, Lotz M: Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes. Arthritis Rheum 32: 1443-1452, 1989.
[5] Di Giovine FS, Malawista SE, Nuki G, Duff GW: Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1. J Immunol 138: 3213-3218, 1987.
[6] Ryckman C, McColl SR, Vandal K, de Medicis R, Lussier A, Poubelle PE, et al.: Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis. Arthritis Rheum 48: 2310-2320, 2003.
[7] Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J: Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440: 237-241, 2006.
[8] Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, et al.: Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9: 847-856, 2008.
[9] Shi Y, Evans JE, Rock KL: Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425: 516-521, 2003.
[10] Eisen AZ, Seegmiller JE: Uric acid metabolism in psoriasis. J Clin Invest 40: 1486-1494, 1961.
[11] Goldman M: Uric acid in the etiology of psoriasis. Am J Dermatopathol 3: 397-404, 1981.
[12] Yata J, Miyasaka N: All of the cytokines. Clinical Immunology & Allergology 57 (suppl. 21): 2012.
[13] Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, et al.: International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58: 281-341, 2006.
[14] Van Den Bossche K, Naeyaert JM, Lambert J. The quest for the mechanism of melanin transfer. Traffic 7: 769-778, 2006.
[15] Piccini A, Carta S, Tassi S, Lasiglie D, Fossati G, Rubartelli A: ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way. Proc Natl Acad Sci U S A 105: 8067-8072, 2008.
[16] Jacques-Silva MC, Rodnight R, Lenz G, Liao Z, Kong Q, Tran M, et al.: P2X7 receptors stimulate AKT phosphorylation in astrocytes. Br J Pharmacol 141: 1106-1117, 2004.
[17] Mamedova LK, Joshi BV, Gao ZG, von Kugelgen I, Jacobson KA. Diisothiocyanate derivatives as potent, insurmountable antagonists of P2Y6 nucleotide receptors. Biochem Pharmacol 67: 1763-1770, 2004.
[18] Liu-Bryan R, Scott P, Sydlaske A, Rose DM, Terkeltaub R: Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum 52: 2936-2946, 2005.
[19] Scott P, Ma H, Viriyakosol S, Terkeltaub R, Liu-Bryan R: Engagement of CD14 mediates the inflammatory potential of monosodium urate crystals. J Immunol 177: 6370-6378, 2006.
[20] Barabe F, Gilbert C, Liao N, Bourgoin SG, Naccache PH: Crystal-induced neutrophil activation VI. Involvment of FcgammaRIIIB (CD16) and CD11b in response to inflammatory microcrystals. FASEB J 12: 209-220, 1998.
[21] Jaques BC, Ginsberg MH: The role of cell surface proteins in platelet stimulation by monosodium urate crystals. Arthritis Rheum 25: 508-521, 1982.
[22] Ng G, Sharma K, Ward SM, Desrosiers MD, Stephens LA, Schoel WM, et al.: Receptor-independent, direct membrane binding leads to cell-surface lipid sorting and Syk kinase activation in dendritic cells. Immunity 29: 807-818, 2008.
[23] Greig AV, Linge C, Terenghi G, McGrouther DA, Burnstock G: Purinergic receptors are part of a functional signaling system for proliferation and differentiation of human epidermal keratinocytes. J Invest Dermatol 120: 1007-1015, 2003.
[24] Taboubi S, Milanini J, Delamarre E, Parat F, Garrouste F, Pommier G, et al.: G alpha(q/11)-coupled P2Y2 nucleotide receptor inhibits human keratinocyte spreading and migration. FASEB J 21: 4047-4058, 2007.
[25] Inoue K, Hosoi J, Denda M: Extracellular ATP has stimulatory effects on the expression and release of IL-6 via purinergic receptors in normal human epidermal keratinocytes. J Invest Dermatol 127: 362-371, 2007.
[26] Pastore S, Mascia F, Gulinelli S, Forchap S, Dattilo C, Adinolfi E, et al.: Stimulation of purinergic receptors modulates chemokine expression in human keratinocytes. J Invest Dermatol 127: 660-667, 2007.
[27] Burrell HE, Bowler WB, Gallagher JA, Sharpe GR: Human keratinocytes express multiple P2Y-receptors: evidence for functional P2Y1, P2Y2, and P2Y4 receptors. J Invest Dermatol 120: 440-447, 2003.
[28] Khine AA, Del Sorbo L, Vaschetto R, Voglis S, Tullis E, Slutsky AS, et al.: Human neutrophil peptides induce interleukin-8 production through the P2Y6 signaling pathway. Blood 107: 2936-2942, 2006.
[29] Grbic DM, Degagne E, Langlois C, Dupuis AA, Gendron FP: Intestinal inflammation increases the expression of the P2Y6 receptor on epithelial cells and the release of CXC chemokine ligand 8 by UDP. J Immunol 180: 2659-2668, 2008.
[30] Warny M, Aboudola S, Robson SC, Sevigny J, Communi D, Soltoff SP, et al.: P2Y(6) nucleotide receptor mediates monocyte interleukin-8 production in response to UDP or lipopolysaccharide. J Biol Chem 276: 26051-26056, 2001.
[31] Cox MA, Gomes B, Palmer K, Du K, Wiekowski M, Wilburn B, et al.: The pyrimidinergic P2Y6 receptor mediates a novel release of proinflammatory cytokines and chemokines in monocytic cells stimulated with UDP. Biochem Biophys Res Commun 330: 467-473, 2005.
[32] Koizumi S, Shigemoto-Mogami Y, Nasu-Tada K, Shinozaki Y, Ohsawa K, Tsuda M, et al.: UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature 446: 1091-1095, 2007.
[33] Sil P, Hayes CP, Reaves BJ, Breen P, Quinn S, Sokolove J, et al.: P2Y6 receptor antagonist MRS2578 inhibits neutrophil activation and aggregated neutrophil extracellular trap formation induced by gout-associated monosodium urate crystals. J Immunol 198: 428-442, 2017.
[34] Somers GR, Hammet FM, Trute L, Southey MC, Venter DJ. Expression of the P2Y6 purinergic receptor in human T cells infiltrating inflammatory bowel disease. Lab Invest 78: 1375-1383, 1998.
[35] Popa-Nita O, Proulx S, Pare G, Rollet-Labelle E, Naccache PH. Crystal-induced neutrophil activation: XI. Implication and novel roles of classical protein kinase C. J Immunol 183: 2104-2114, 2009.
[36] Brüser A, Zimmermann A, Crews BC, Sliwoski G, Meiler J, König GM, et al.: Prostaglandin E2 glyceryl ester is an endogenous agonist of the nucleotide receptor P2Y6. Sci Rep 7: 2380. 2017.
[37] Uratsuji H, Tada Y, Hau CS, Shibata S, Kamata M, Kawashima T, et al.: Monosodium urate crystals induce functional expression of P2Y14 receptor in human keratinocytes. J Invest Dermatol 136: 1293-1296, 2016.
[38] Watanabe H, Gaide O, Petrilli V, Martinon F, Contassot E, Roques S, et al.: Activation of the IL-1beta-processing inflammasome is involved in contact hypersensitivity. J Invest Dermatol 127: 1956-1963, 2007.
[39] Kupper TS: Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations. J Clin Invest 86: 1783-1789, 1990.
[40] Yano S, Banno T, Walsh R, Blumenberg M: Transcriptional responses of human epidermal keratinocytes to cytokine interleukin-1. J Cell Physiol 214: 1-13, 2008.
[41] Groves RW, Mizutani H, Kieffer JD, Kupper TS. Inflammatory skin disease in transgenic mice that express high levels of interleukin 1 alpha in basal epidermis. Proc Natl Acad Sci U S A 92: 11874-11878, 1995.